coumaran has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Chen, Z; Ding, J; Duan, W; Ning, Y; Wu, Q; Xie, H; Xue, Y; Zhang, H; Zhou, J | 1 |
1 other study(ies) available for coumaran and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Design, synthesis and pharmacological evaluation of 2,3-dihydrobenzofuran IRAK4 inhibitors for the treatment of diffuse large B-cell lymphoma.
Topics: Cell Line, Tumor; Humans; Interleukin-1 Receptor-Associated Kinases; Lymphoma, Large B-Cell, Diffuse; Myeloid Differentiation Factor 88 | 2023 |